Araştırma Makalesi
PDF Zotero Mendeley EndNote BibTex Kaynak Göster

Yıl 2021, Cilt 4, Sayı 6, 800 - 808, 24.09.2021
https://doi.org/10.32322/jhsm.963439

Öz

Kaynakça

  • Reddy AG, Alzweri LM, Gabrielson AT, Leinwand G, Hellstrom WJG. Role of Penile Prosthesis in Priapism: A Review. World J Mens Health 2018; 36: 4-14.
  • Tay YK, Spernat D, Rzetelski-West K, Appu S, Love C. Acute management of priapism in men. BJU Int 2012; 109: 15-21.
  • Ridgley J, Raison N, Sheikh MI, Dasgupta P, Khan MS, Ahmed K. Ischaemic priapism: A clinical review. Turk J Urol 2017; 43: 1-8.
  • Yılmaz Y, Taken K, Atar M, Ergün M, Söylemez H. Protective effect of curcumin on priapism and ischemia-reperfusion injury in rats. Eur Rev Med Pharmacol Sci 2015; 19: 4664-70.
  • Karaguzel E, Bayraktar C, Kutlu O, et al. The possible protective effects of dipyridamole on ischemic reperfusion injury of priapism. Int Braz J Urol 2016; 42: 146-53.
  • Uluocak N, Atılgan D, Erdemir F, et al. An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis. Int Urol Nephrol 2010; 42: 889-95.
  • Erdemir F, Firat F, Markoc F, et al. The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model. Int Urol Nephrol 2014; 46: 1961-7.
  • Ciftci O, Oguz F, Beytur A, Polat F, Altıntas R, Oguzturk H. Lycopene prevents experimental priapism against oxidative and nitrosative damage. Eur Rev Med Pharmacol Sci 2014; 18: 3320-5.
  • Çevik Ö, Çadırcı S, Şener TE, et al. Quercetin treatment against ischemia/reperfusion injury in rat corpus cavernosum tissue: a role on apoptosis and oxidative stress. Free Radic Res 2013; 47: 683-91.
  • Koca R. Dapsone. Turkiye Klinikleri Dermatology 2014; 7: 43-8.
  • Dejban P, Rahimi N, Takzare N, Jahansouz M, Haddadi NS, Dehpour AR. Beneficial effects of dapsone on ischemia/reperfusion injury following torsion/detorsion in ipsilateral and contralateral testes in rat. Theriogenology 2019; 140: 136-42.
  • Sheibani M, Nezamoleslami S, Faghir-Ghanesefat H, Hossein Emami A, Dehpour AR. Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. Cancer Chemother Pharmacol 2020; 85: 563-71.
  • Ríos C, Orozco-Suarez S, Salgado-Ceballos H, et al. Anti-Apoptotic Effects of Dapsone After Spinal Cord Injury in Rats. Neurochem Res 2015; 40: 1243-51.
  • Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res 2014; 306: 103-24.
  • Liang SE, Hoffmann R, Peterson E, Soter NA. Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria. JAMA Dermatol 2019; 155: 90-5.
  • Diaz-Ruiz A, Mendez-Armenta M, Galván-Arzate S, et al. Antioxidant, anticonvulsive and neuroprotective effects of dapsone and phenobarbital against kainic acid-induced damage in rats. Neurochem Res 2013; 38: 1819-27.
  • Abe M, Shimizu A, Yokoyama Y, Takeuchi Y, Ishikawa O. A possible inhibitory action of diaminodiphenyl sulfone on tumour necrosis factor-alpha production from activated mononuclear cells on cutaneous lupus erythematosus. Clin Exp Dermatol 2008; 33: 759-63.
  • Nezamoleslami S, Sheibani M, Jahanshahi F, Mumtaz F, Abbasi A, Dehpour AR. Protective effect of dapsone against renal ischemia-reperfusion injury in rat. Immunopharmacol Immunotoxicol 2020; 42: 272-9.
  • Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-21.
  • Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-78.
  • Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
  • Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
  • Erel, O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 2004; 37: 112-9.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005; 38: 1103-11.
  • Senturk GE, Erkanli K, Aydin U, et al. The protective effect of oxytocin on ischemia/reperfusion injury in rat urinary bladder. Peptides 2013; 40: 82-8.
  • Levey HR, Segal RL, Bivalacqua TJ. Management of priapism: an update for clinicians. Ther Adv Urol 2014; 6: 230-44.
  • El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int 2002; 89: 285-90.
  • Pal DK, Biswal DL, Ghosh B. Outcome and erectile function following treatment of priapism: An institutional experience. Urol Ann 2016; 8: 46-50.
  • Kulmala RV, Lehtonen TA, Tammela TL. Preservation of potency after treatment for priapism. Scand J Urol Nephrol 1996; 30: 313-6.
  • Sener G, Paskaloğlu K, Sehirli AO, Dülger GA, Alican I. The effects of melatonin on ischemia-reperfusion induced changes in rat corpus cavernosum. J Urol 2002; 167: 2624-7.
  • Wu MY, Yiang GT, Liao WT, et al. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem 2018; 46: 1650-67.
  • Taati M, Moghadasi M, Dezfoulian O, Asadian P. Effects of ghrelin on testicular ıschemia/reperfusion-ınduced ınjury. Acta Med Iran 2016; 54: 32-8.
  • Munarriz R, Park K, Huang YH, et al. Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism. Urology 2003; 62: 760-4.
  • Salehzadeh F, Jahangiri S, Mohammadi E. Dapsone as an alternative therapy in children with familial mediterranean Fever. Iran J Pediatr 2012; 22: 23-7.
  • Lee JH, Choi SH, Lee CJ, Oh SS. Recovery of dementia syndrome following treatment of brain inflammation. Dement Geriatr Cogn Dis Extra 2020; 10: 1-12.
  • Ríos C, Nader-Kawachi J, Rodriguez-Payán AJ, Nava-Ruiz C. Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats. Brain Res 2004; 999: 212-5.
  • Diaz-Ruiz A, Roldan-Valadez E, Ortiz-Plata A, et al. Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats. Brain Res 2016; 1646: 384-92.

Dapsone can be a new treatment option for reducing the detrimental effect of priapism

Yıl 2021, Cilt 4, Sayı 6, 800 - 808, 24.09.2021
https://doi.org/10.32322/jhsm.963439

Öz

Aim: This study aims to analyze the effect of dapsone against ischaemia-reperfusion injury on corporal tissue in a model of induced-priapism in rats. Material and Method: A total of 24 rats were randomized into three groups. Group 1 was defined as the control group. Ischaemia-reperfusion injury was evaluated following the priapism model in Group 2. Group 3 had similar procedures to the rats in Group 2. Group 3 additionally had 12.5 mg/kg dapsone administered intraperitoneally 30 minutes after priapism. Results: Biochemical analysis of blood indicated a significant increase in Group 3 in terms of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) activity and total antioxidant status (TAS) values compared with Group 2 (p:0.002, p:0.029 and p:0.009, respectively). The highest values of malondialdehyde (MDA), protein carbonyl (PC) and total oxidant status (TOS) were recorded in Group 2 (p<0.001). Interleukin 1beta (IL-1beta), Interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF alpha) levels were found to be significantly decreased in Group 3 compared with Group 2 (p:0.022, p:0.049 and p<0.001, respectively). Direct microscopic evaluation determined an improvement in inflammation, edema, desquamation and vasocongestion scores in Group 3 compared to Group 2 (p<0.05). Conclusion: Dapsone has a protective effect on ischaemia-reperfusion injury in corporal tissue.

Kaynakça

  • Reddy AG, Alzweri LM, Gabrielson AT, Leinwand G, Hellstrom WJG. Role of Penile Prosthesis in Priapism: A Review. World J Mens Health 2018; 36: 4-14.
  • Tay YK, Spernat D, Rzetelski-West K, Appu S, Love C. Acute management of priapism in men. BJU Int 2012; 109: 15-21.
  • Ridgley J, Raison N, Sheikh MI, Dasgupta P, Khan MS, Ahmed K. Ischaemic priapism: A clinical review. Turk J Urol 2017; 43: 1-8.
  • Yılmaz Y, Taken K, Atar M, Ergün M, Söylemez H. Protective effect of curcumin on priapism and ischemia-reperfusion injury in rats. Eur Rev Med Pharmacol Sci 2015; 19: 4664-70.
  • Karaguzel E, Bayraktar C, Kutlu O, et al. The possible protective effects of dipyridamole on ischemic reperfusion injury of priapism. Int Braz J Urol 2016; 42: 146-53.
  • Uluocak N, Atılgan D, Erdemir F, et al. An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis. Int Urol Nephrol 2010; 42: 889-95.
  • Erdemir F, Firat F, Markoc F, et al. The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model. Int Urol Nephrol 2014; 46: 1961-7.
  • Ciftci O, Oguz F, Beytur A, Polat F, Altıntas R, Oguzturk H. Lycopene prevents experimental priapism against oxidative and nitrosative damage. Eur Rev Med Pharmacol Sci 2014; 18: 3320-5.
  • Çevik Ö, Çadırcı S, Şener TE, et al. Quercetin treatment against ischemia/reperfusion injury in rat corpus cavernosum tissue: a role on apoptosis and oxidative stress. Free Radic Res 2013; 47: 683-91.
  • Koca R. Dapsone. Turkiye Klinikleri Dermatology 2014; 7: 43-8.
  • Dejban P, Rahimi N, Takzare N, Jahansouz M, Haddadi NS, Dehpour AR. Beneficial effects of dapsone on ischemia/reperfusion injury following torsion/detorsion in ipsilateral and contralateral testes in rat. Theriogenology 2019; 140: 136-42.
  • Sheibani M, Nezamoleslami S, Faghir-Ghanesefat H, Hossein Emami A, Dehpour AR. Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. Cancer Chemother Pharmacol 2020; 85: 563-71.
  • Ríos C, Orozco-Suarez S, Salgado-Ceballos H, et al. Anti-Apoptotic Effects of Dapsone After Spinal Cord Injury in Rats. Neurochem Res 2015; 40: 1243-51.
  • Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res 2014; 306: 103-24.
  • Liang SE, Hoffmann R, Peterson E, Soter NA. Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria. JAMA Dermatol 2019; 155: 90-5.
  • Diaz-Ruiz A, Mendez-Armenta M, Galván-Arzate S, et al. Antioxidant, anticonvulsive and neuroprotective effects of dapsone and phenobarbital against kainic acid-induced damage in rats. Neurochem Res 2013; 38: 1819-27.
  • Abe M, Shimizu A, Yokoyama Y, Takeuchi Y, Ishikawa O. A possible inhibitory action of diaminodiphenyl sulfone on tumour necrosis factor-alpha production from activated mononuclear cells on cutaneous lupus erythematosus. Clin Exp Dermatol 2008; 33: 759-63.
  • Nezamoleslami S, Sheibani M, Jahanshahi F, Mumtaz F, Abbasi A, Dehpour AR. Protective effect of dapsone against renal ischemia-reperfusion injury in rat. Immunopharmacol Immunotoxicol 2020; 42: 272-9.
  • Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-21.
  • Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-78.
  • Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
  • Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
  • Erel, O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clinical Biochemistry 2004; 37: 112-9.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clinical Biochemistry 2005; 38: 1103-11.
  • Senturk GE, Erkanli K, Aydin U, et al. The protective effect of oxytocin on ischemia/reperfusion injury in rat urinary bladder. Peptides 2013; 40: 82-8.
  • Levey HR, Segal RL, Bivalacqua TJ. Management of priapism: an update for clinicians. Ther Adv Urol 2014; 6: 230-44.
  • El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int 2002; 89: 285-90.
  • Pal DK, Biswal DL, Ghosh B. Outcome and erectile function following treatment of priapism: An institutional experience. Urol Ann 2016; 8: 46-50.
  • Kulmala RV, Lehtonen TA, Tammela TL. Preservation of potency after treatment for priapism. Scand J Urol Nephrol 1996; 30: 313-6.
  • Sener G, Paskaloğlu K, Sehirli AO, Dülger GA, Alican I. The effects of melatonin on ischemia-reperfusion induced changes in rat corpus cavernosum. J Urol 2002; 167: 2624-7.
  • Wu MY, Yiang GT, Liao WT, et al. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem 2018; 46: 1650-67.
  • Taati M, Moghadasi M, Dezfoulian O, Asadian P. Effects of ghrelin on testicular ıschemia/reperfusion-ınduced ınjury. Acta Med Iran 2016; 54: 32-8.
  • Munarriz R, Park K, Huang YH, et al. Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism. Urology 2003; 62: 760-4.
  • Salehzadeh F, Jahangiri S, Mohammadi E. Dapsone as an alternative therapy in children with familial mediterranean Fever. Iran J Pediatr 2012; 22: 23-7.
  • Lee JH, Choi SH, Lee CJ, Oh SS. Recovery of dementia syndrome following treatment of brain inflammation. Dement Geriatr Cogn Dis Extra 2020; 10: 1-12.
  • Ríos C, Nader-Kawachi J, Rodriguez-Payán AJ, Nava-Ruiz C. Neuroprotective effect of dapsone in an occlusive model of focal ischemia in rats. Brain Res 2004; 999: 212-5.
  • Diaz-Ruiz A, Roldan-Valadez E, Ortiz-Plata A, et al. Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats. Brain Res 2016; 1646: 384-92.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Bilimleri ve Hizmetleri
Bölüm Orijinal Makale
Yazarlar

Engin KÖLÜKÇÜ (Sorumlu Yazar)
Tokat Gaziosmanpasa University Faculty of Medicine, Department of Urology
0000-0003-3387-4428
Türkiye


Bekir Süha PARLAKTAŞ
Tokat Gaziosmanpasa University Faculty of Medicine, Department of Urology
0000-0001-8754-4155
Türkiye


Nihat ULUOCAK
Tokat Gaziosmanpasa University Faculty of Medicine, Department of Urology
0000-0001-8315-466X
Türkiye


Faik DERESOY
Tokat Gaziosmanpasa University Faculty of Medicine, Department of Pathology
0000-0002-2243-9394
Türkiye


Muzaffer KATAR
Tokat Gaziosmanpasa University Faculty of Medicine, Department of Biochemistry
0000-0002-6296-2390
Türkiye


Velid UNSAL
Mardin Artuklu University, Faculty of Health Sciences and Central Research Laboratory
0000-0003-1415-0563
Türkiye

Yayımlanma Tarihi 24 Eylül 2021
Yayınlandığı Sayı Yıl 2021, Cilt 4, Sayı 6

Kaynak Göster

Bibtex @araştırma makalesi { jhsm963439, journal = {Journal of Health Sciences and Medicine}, issn = {}, eissn = {2636-8579}, address = {Kırıkkale Üniversitesi Tıp Fakültesi / İç Hastalıkları Anabilim Dalı}, publisher = {MediHealth Academy Yayıncılık}, year = {2021}, volume = {4}, pages = {800 - 808}, doi = {10.32322/jhsm.963439}, title = {Dapsone can be a new treatment option for reducing the detrimental effect of priapism}, key = {cite}, author = {Kölükçü, Engin and Parlaktaş, Bekir Süha and Uluocak, Nihat and Deresoy, Faik and Unsal, Velid} }
APA Kölükçü, E. , Parlaktaş, B. S. , Uluocak, N. , Deresoy, F. , Katar, M. & Unsal, V. (2021). Dapsone can be a new treatment option for reducing the detrimental effect of priapism . Journal of Health Sciences and Medicine , 4 (6) , 800-808 . DOI: 10.32322/jhsm.963439
MLA Kölükçü, E. , Parlaktaş, B. S. , Uluocak, N. , Deresoy, F. , Katar, M. , Unsal, V. "Dapsone can be a new treatment option for reducing the detrimental effect of priapism" . Journal of Health Sciences and Medicine 4 (2021 ): 800-808 <https://dergipark.org.tr/tr/pub/jhsm/issue/64996/963439>
Chicago Kölükçü, E. , Parlaktaş, B. S. , Uluocak, N. , Deresoy, F. , Katar, M. , Unsal, V. "Dapsone can be a new treatment option for reducing the detrimental effect of priapism". Journal of Health Sciences and Medicine 4 (2021 ): 800-808
RIS TY - JOUR T1 - Dapsone can be a new treatment option for reducing the detrimental effect of priapism AU - Engin Kölükçü , Bekir Süha Parlaktaş , Nihat Uluocak , Faik Deresoy , Muzaffer Katar , Velid Unsal Y1 - 2021 PY - 2021 N1 - doi: 10.32322/jhsm.963439 DO - 10.32322/jhsm.963439 T2 - Journal of Health Sciences and Medicine JF - Journal JO - JOR SP - 800 EP - 808 VL - 4 IS - 6 SN - -2636-8579 M3 - doi: 10.32322/jhsm.963439 UR - https://doi.org/10.32322/jhsm.963439 Y2 - 2021 ER -
EndNote %0 Journal of Health Sciences and Medicine Dapsone can be a new treatment option for reducing the detrimental effect of priapism %A Engin Kölükçü , Bekir Süha Parlaktaş , Nihat Uluocak , Faik Deresoy , Muzaffer Katar , Velid Unsal %T Dapsone can be a new treatment option for reducing the detrimental effect of priapism %D 2021 %J Journal of Health Sciences and Medicine %P -2636-8579 %V 4 %N 6 %R doi: 10.32322/jhsm.963439 %U 10.32322/jhsm.963439
ISNAD Kölükçü, Engin , Parlaktaş, Bekir Süha , Uluocak, Nihat , Deresoy, Faik , Katar, Muzaffer , Unsal, Velid . "Dapsone can be a new treatment option for reducing the detrimental effect of priapism". Journal of Health Sciences and Medicine 4 / 6 (Eylül 2021): 800-808 . https://doi.org/10.32322/jhsm.963439
AMA Kölükçü E. , Parlaktaş B. S. , Uluocak N. , Deresoy F. , Katar M. , Unsal V. Dapsone can be a new treatment option for reducing the detrimental effect of priapism. J Health Sci Med / JHSM. 2021; 4(6): 800-808.
Vancouver Kölükçü E. , Parlaktaş B. S. , Uluocak N. , Deresoy F. , Katar M. , Unsal V. Dapsone can be a new treatment option for reducing the detrimental effect of priapism. Journal of Health Sciences and Medicine. 2021; 4(6): 800-808.
IEEE E. Kölükçü , B. S. Parlaktaş , N. Uluocak , F. Deresoy , M. Katar ve V. Unsal , "Dapsone can be a new treatment option for reducing the detrimental effect of priapism", Journal of Health Sciences and Medicine, c. 4, sayı. 6, ss. 800-808, Eyl. 2021, doi:10.32322/jhsm.963439

Interuniversity Board (UAK) Equivalency: Ulakbim TR Dizin and 1b [Original research article published in journals scanned by international field indexes (included in indices other than the ones mentioned in 1a) - 10 POINTS]. The Directories (indexes) and Platforms we are included in are at the bottom of the page. 



The indexes of the journal are;

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are;

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Assoc. Prof. Alpaslan TANOĞLU (MD) was qualified as an Editor in Chief in JHSM on 27/09/2020.

Prof. Yavuz BEYAZIT (MD) was qualified as an Editor in JHSM on 01/02/2021. 

Assoc. Prof. Bekir UÇAN (MD) was qualified as an Associated Editor in JHSM on 15/02/2020.

Assoc. Prof. Oğuz EROĞLU (MD) was qualified as an Associated Editor in JHSM on 15/02/2020. 

Prof. Murat KEKİLLİ (MD) was qualified as an Associated Editor in JHSM on 01/02/2021. 


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.